M. Grabowski, “Trying to select among three antihypertensive drugs: ramipril, telmisartan and valsartan in the treatment of hypertension according to the blood pressure and cardiovascular risk”, J EBM, vol. 5, no. 4(17), pp. 39-46, Dec. 2012.